Antiretroviral Strategies to Prevent Mother-to-Child Transmission of HIV: Striking a Balance between Efficacy, Feasibility, and Resistance

Dara Lehman and colleagues discuss a randomized trial that found that adding up to a week of twice-daily zidovudine+lamivudine to single-dose nevirapine reduces the risk of resistance in mothers and infants.

Detalles Bibliográficos
Autores principales: Lehman, Dara A., John-Stewart, Grace C., Overbaugh, Julie
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760781/
https://www.ncbi.nlm.nih.gov/pubmed/19859532
http://dx.doi.org/10.1371/journal.pmed.1000169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760781/
https://www.ncbi.nlm.nih.gov/pubmed/19859532
http://dx.doi.org/10.1371/journal.pmed.1000169

Ejemplares similares